Use of Injection Drugs and Any Form of Methamphetamine in the Portland, OR Metro Area as a Driver of an HIV Time-Space Cluster: Clackamas, Multnomah, and Washington Counties, 2018-2020.
Epidemiology
HIV cluster investigation
Injection drug use
Non-injection methamphetamine
Surveillance
Journal
AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
accepted:
23
10
2021
pubmed:
11
11
2021
medline:
30
4
2022
entrez:
10
11
2021
Statut:
ppublish
Résumé
We describe the response to detection of a time-space cluster of new HIV infection in the Portland, OR metro area among people who inject drugs (PWID) and/or people who use any form of methamphetamine. This time-space cluster took place in a region with a syndemic of homelessness and drug use. The investigation included new HIV diagnoses in 2018, 2019, and 2020 in Clackamas, Multnomah, and Washington Counties. Public health response included activating incident command, development and implementation of an enhanced interview tool, outreach testing, and stakeholder engagement. We identified 396 new cases of HIV infection, 116 (29%) of which met the cluster definition. Most cluster cases had no molecular relationships to previous cases. Persons responding to the enhanced interview tool reported behaviors associated with HIV acquisition. Field outreach testing did not identify any new HIV cases but did identify hepatitis C and syphilis infections. We show the importance of a robust public health response to a time-space cluster of new HIV infections in an urban area.
Identifiants
pubmed: 34757494
doi: 10.1007/s10461-021-03522-3
pii: 10.1007/s10461-021-03522-3
pmc: PMC8579413
doi:
Substances chimiques
Methamphetamine
44RAL3456C
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1717-1726Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Centers for Disease Control and Prevention. Managing HIV and hepatitis C outbreaks among people who inject drugs—A guide for state and local health departments. 2018. https://www.cdc.gov/hiv/pdf/programresources/guidance/cluster-outbreak/cdc-hiv-hcv-pwid-guide.pdf . Accessed 3 Mar 2021.
Hodder SL, Feinberg J, Strathdee SA, et al. The opioid crisis and HIV in the USA: deadly synergies. Lancet. 2021;397(10279):1139–50.
doi: 10.1016/S0140-6736(21)00391-3
Oregon Health Authority, Public Health Division. Epidemiologic profile of HIV infection in Oregon. 2018. https://sharedsystems.dhsoha.state.or.us/DHSForms/Served/le9998.pdf . Accessed 3 Mar 2021.
Oregon Health Authority, Public Health Division. Injection Drug Use and HIV in Oregon. 2018. https://sharedsystems.dhsoha.state.or.us/DHSForms/Served/le9988.pdf . Accessed 3 Mar 2021.
Mitsch AJ, Hall HI, Babu AS. Trends in HIV infection among persons who inject drugs: United States and Puerto Rico, 2008–2013. Am J Public Health. 2016;106(12):2194–201.
doi: 10.2105/AJPH.2016.303380
Multnomah County. Health officials alert public to increase in HIV infections among people who use drugs. 2019. https://www.multco.us/multnomah-county/news/health-officials-alert-public-increase-hiv-infections-among-people-who-use . Accessed 10 Aug 2021.
Oregon Health Authority, Public Health Division. Opioid Overdose in Oregon: Report to the Legislature. 2018. https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/SUBSTANCEUSE/OPIOIDS/Documents/OHA2479.pdf . Accessed 3 Mar 2021.
Hedberg K, Bui L, Livingston C, Shields LM, Van Otterloo J. Integrating public health and health care strategies to address the opioid epidemic: the Oregon Health Authority’s Opioid Initiative. J Public Health Manag Pract. 2019;25(3):214–20.
doi: 10.1097/PHH.0000000000000849
CDC WONDER. Multiple Cause of Death 1999–2019. Centers for Disease Control and Prevention, National Center for Health Statistics. 2020. https://wonder.cdc.gov . Accessed 2 Mar 2021.
Alpren C, Dawson EL, John B, et al. Opioid use fueling HIV transmission in an urban setting: an outbreak of HIV infection among people who inject drugs-Massachusetts, 2015–2018. Am J Public Health. 2020;110(1):37–44.
doi: 10.2105/AJPH.2019.305366
Conrad C, Bradley HM, Broz D, et al. Community outbreak of HIV infection linked to injection drug use of oxymorphone-Indiana, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(16):443–4.
pubmed: 25928470
pmcid: 4584812
Glick SN, Burt R, Kummer K, et al. Increasing methamphetamine injection among non-MSM who inject drugs in King County, Washington. Drug Alcohol Depend. 2018;182:86–92.
doi: 10.1016/j.drugalcdep.2017.10.011
Golden MR, Lechtenberg R, Glick SN. Outbreak of human immunodeficiency virus infection among heterosexual persons who are living homeless and inject drugs - Seattle, Washington, 2018. MMWR Morb Mortal Wkly Rep. 2019;68(15):344–9.
doi: 10.15585/mmwr.mm6815a2
Peters PJ, Pontones P, Hoover KW, et al. HIV infection linked to injection use of oxymorphone in Indiana, 2014–2015. N Engl J Med. 2016;375(3):229–39.
doi: 10.1056/NEJMoa1515195
Atkins A, McClung RP, Kilkenny M, et al. Notes from the field: outbreak of human immunodeficiency virus infection among persons who inject drugs - Cabell County, West Virginia, 2018–2019. MMWR Morb Mortal Wkly Rep. 2020;69(16):499–500.
doi: 10.15585/mmwr.mm6916a2
Kerr T, Small W, Buchner C, et al. Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. Am J Public Health. 2010;100(8):1449–53.
doi: 10.2105/AJPH.2009.178467
Fauci AS, Redfield R, Sigounas G, Weahkee M, Giroir B. Ending the HIV epidemic: a plan for the United States. JAMA. 2019;321(9):844–5.
doi: 10.1001/jama.2019.1343
Centers for Disease Control and Prevention. Detecting and responding to HIV Transmission clusters. A guide for health departments. June 2018. https://www.cdc.gov/hiv/pdf/funding/announcements/ps18-1802/CDC-HIV-PS18-1802-AttachmentE-Detecting-Investigating-and-Responding-to-HIV-Transmission-Clusters.pdf . Accessed 2 Mar 2021.
Dennis AM, Pasquale DK, Billock R, et al. Integration of contact tracing and phylogenetics in an investigation of acute HIV infection. Sex Transm Dis. 2018;45(4):222–8.
doi: 10.1097/OLQ.0000000000000726
Oster AM, France AM, Mermin J. Molecular epidemiology and the transformation of HIV prevention. JAMA. 2018;319(16):1657–8.
doi: 10.1001/jama.2018.1513
Oster AM, France AM, Panneer N, et al. Identifying clusters of recent and rapid HIV transmission through analysis of molecular surveillance data. J Acquir Immune Defic Syndr. 2018;79(5):543–50.
doi: 10.1097/QAI.0000000000001856
Oregon Health Authority, Public Health Division. Oregon Disease Investigative Guidelines. HIV Infection and AIDS. 2012. https://www.oregon.gov/oha/PH/DISEASESCONDITIONS/COMMUNICABLEDISEASE/REPORTINGCOMMUNICABLEDISEASE/REPORTINGGUIDELINES/Documents/hiv_aids.pdf . Accessed 12 Feb 2021.
Oregon Health Authority, Public Health Division. Oregon Disease Investigative Guidelines. Hepatitis C. 2020. https://www.oregon.gov/oha/PH/DISEASESCONDITIONS/COMMUNICABLEDISEASE/REPORTINGCOMMUNICABLEDISEASE/REPORTINGGUIDELINES/Documents/hepc.pdf . Accessed 13 Aug 2021.
INSTI HIV-1/HIV-2 antibody test kit [package insert]. Richmond, BC, Canada: bioLytical Laboratories. 2019.
Oregon Health Authority, Public Health Division. A Quick Introduction to Medications For Opioid Use Disorder. 2019. https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/SUBSTANCEUSE/OPIOIDS/Documents/MOUD-factsheet.pdf . Accessed 8 Apr 2021.
Oregon Health Authority. OHA sees 70% increase in Oregon drug overdose deaths during April, May. 2020. https://www.oregon.gov/oha/ERD/Pages/OHA-sees-70-percent-increase-in-Oregon-opioid-deaths-during-April-May.aspx . Accessed 8 Apr 2021.
Lyss SB, Buchacz K, McClung RP, Asher A, Oster AM. Responding to outbreaks of human immunodeficiency virus among persons who inject drugs-United States, 2016–2019: perspectives on recent experience and lessons learned. J Infect Dis. 2020;222(Suppl 5):S239–49.
doi: 10.1093/infdis/jiaa112
National Institute of Allergy and Infectious Diseases. Pre-exposure Prophylaxis (PrEP) to Reduce HIV Risk. 2020. https://www.niaid.nih.gov/diseases-conditions/pre-exposure-prophylaxis-prep . Accessed 9 Apr 2021.
Centers for Disease Control and Prevention. Pre-exposure Prophylaxis (PrEP) Care System. 2020. https://www.cdc.gov/hiv/effectiveinterventions/prevent/prep/index.html . Accessed 9 Apr 2021.
Lipira L. and Bhattara A. National HIV Behavioral Surveillance, IDU5 2018. Chime In updates: Key findings from cycle 5, people who inject drugs in the Portland MSA. 2019: Portland, OR.
Oregon Health Authority, Public Health Division. Experiences of PrEP Use among People Recently Diagnosed with HIV in Oregon, 2016–2019. 2020. https://www.oregon.gov/oha/PH/DISEASESCONDITIONS/HIVSTDVIRALHEPATITIS/HIVPREVENTION/Documents/Experiences_of_PrEP_Use_Among_People_Recently_Diagnosed_with_HIV.pdf . Accessed 9 Apr 2021.
Furukawa NW, Blau EF, Reau Z, et al. Missed opportunities for human immunodeficiency virus (HIV) testing during injection drug use-related healthcare encounters among a cohort of persons who inject drugs with HIV diagnosed during an outbreak-Cincinnati/Northern Kentucky, 2017–2018. Clin Infect Dis. 2020;72(11):1961–7.
doi: 10.1093/cid/ciaa507
Capizzi J, Leahy J, Wheelock H, et al. Population-based trends in hospitalizations due to injection drug use-related serious bacterial infections, Oregon, 2008 to 2018. PLoS ONE. 2020;15(11):e0242165.
doi: 10.1371/journal.pone.0242165
Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55:1–17.
pubmed: 16988643
Escudero DJ, Bahamon M, Panakos P, et al. How to best conduct universal HIV screening in emergency departments is far from settled. J Am Coll Emerg Phys Open. 2021;2(1):e12352.
Escudero DJ, Bennett B, Suarez S, et al. Progress and challenges in “getting to zero” new HIV infections in Miami, Florida. J Int Assoc Provid AIDS Care. 2019;18:2325958219852122.
doi: 10.1177/2325958219852122
Trivedi MH, Walker R, Ling W, Dela Cruz A, Sharma G, Carmody T, Ghitza UE, Wahle A, Kim M, Shores-Wilson K, Sparenborg S, Coffin P, Schmitz J, Wiest K, Bart G, Sonne SC, Wakhlu S, Rush AJ, Nunes EV, Shoptaw S. Bupropion and naltrexone in methamphetamine use disorder. N Engl J Med. 2021;384(2):140–53.
doi: 10.1056/NEJMoa2020214
National Institute of Drug Abuse, National Institutes of Health, U.S. Department of Health and Human Services. October 2019. Methamphetamine Research Report. https://www.drugabuse.gov/download/37620/methamphetamine-research-report.pdf?v=f6a96a8721a56a0f765889a3d3e678c7 . Accessed 9 Apr 2021.
Glick SN, Klein KS, Tinsley J, Golden MR. Increasing heroin-methamphetamine (goofball) use and related morbidity among seattle area people who inject drugs. Am J Addict. 2021;30(2):183–91.
doi: 10.1111/ajad.13115
Meacham MC, Strathdee SA, Rangel G, et al. Prevalence and correlates of heroin-methamphetamine co-injection among persons who inject drugs in San Diego, California, and Tijuana, Baja California, Mexico. J Stud Alcohol Drugs. 2016;77(5):774–81.
doi: 10.15288/jsad.2016.77.774
Frieden TR, Foti KE, Mermin J. Applying public health principles to the HIV epidemic-how are we doing? N Engl J Med. 2015;373(23):2281–7.
doi: 10.1056/NEJMms1513641